Qilu Pharmaceutical (Hainan) Co., Ltd. was established in 2005, with the registered capital of 5 million US dollars.
There are more than 500 people employed by the company and it is a key large enterprise introduced by the Hainan Provincial Government in the industrial strategy of “Introducing large-scale enterprises; driven by large projects”.
It is also a large comprehensive modern pharmaceutical enterprise invested heavily in by Qilu Pharmaceutical Group to construct an “export pharmaceutics production base” in Haikou under the favorable investment environment and privileged policies in Hainan.
The company develops, manufactures and sells mainly cardiovascular series amongst other products.
Address No. 273-A, Nanhai Avenue, National High-Tech 570314 Zone,